Healthcare -
Biotechnology - NASDAQ - US
$ 3.6301
4.61 %
$ 2.65 B
Market Cap
-4.03
P/E
Price Target
Average
65.28%
Revenue Forecast
Estimate
1430.90%
EBIT
Estimate
--83.32%
Net Income
Estimate
45.66%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
ImmunityBio, Inc.
Wall Street analysts predict an average 1-year price target for IBRX of $6 , with forecasts ranging from
a
low of
$6 to a high of $6 .
IBRX Lowest Price Target
Wall Street Target
6 USD
65.28%
IBRX Average Price Target
Wall Street Target
6 USD
65.28%
IBRX Highest Price Target
Wall Street Target
6 USD
65.28%
REVENUE FORECAST
Revenue Forecast Chart IBRX
EBIT FORECAST
EBIT Forecast Chart IBRX
NET INCOME FORECAST
Net Income Chart IBRX